SOPHIA GENETICS SA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.03 USD | +1.62% |
|
+1.41% | +6.79% |
| 23/04 | Sophia Genetics Says Nigeria's Syndicate Bio Signs on to Implement Liquid Biopsy Offering | MT |
| 23/04 | SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa | CI |
Chart calendar SOPHiA GENETICS SA
fa51072b36f6cbb.Tl3OVtr3wPNWepBVxMWHYdz35WVvi4gWrTgq0De9MHs.eBeMGo-wpJUHNdtjoIu_C6-YlBQr7qVY60xYnEHPZRMFGrsSo8_1qWU_3Q~17fbea1be65efb733a9d617dadb21112
Upcoming events on SOPHiA GENETICS SA
Past events on SOPHiA GENETICS SA
| 14/03/2024 12:05 am | Barclays Global Healthcare Conference |
| 06/03/2024 09:00 pm | TD Cowen Health Care Conference |
| 05/03/2024 06:30 pm | Q4 2023 Earnings Call |
| 05/03/2024 05:15 pm | Q4 2023 Earnings Release |
| 11/01/2024 10:30 pm | JPMorgan Healthcare Conference |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 07/11/2023 05:00 pm | Q3 2023 Earnings Release |
| 04/11/2023 01:00 am | American Society of Human Genetics Meeting |
| 20/09/2023 | SFMPP Conference |
| 09/09/2023 | European Pathology Congress |
| 08/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 08/08/2023 04:40 pm | Q2 2023 Earnings Release |
| 26/06/2023 05:30 pm | Annual General Meeting |
| 18/06/2023 | Association for Molecular Pathology Conference |
| 10/06/2023 | European Society of Human Genetics Meeting |
| 02/06/2023 | American Society of Clinical Oncology Meeting |
| 09/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 09/05/2023 04:25 pm | Q1 2023 Earnings Release |
| 16/04/2023 11:00 pm | American Association for Cancer Research Meeting |
| 17/03/2023 10:00 pm | American College of Medical Genetics Meeting |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 40,5 40,8 -0.91% | 47,6 47,1 0.96% | 62,4 62,5 -0.2% | 79,4 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -67,9 -67,8 -0.08% | -82,3 -86,9 5.3% | -66,5 -64,8 -2.54% | -57,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -71,5 -71,4 -0.13% | -87,8 -92,9 5.49% | -74,8 -72,7 -2.99% | -60,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -73,5 -71,8 -2.34% | -87,6 -96,7 9.39% | -78,5 -71,5 -9.85% | -63,8 |
|
Net income Million USD | Released Forecast Spread | -39,3 | -73,7 -73,2 -0.59% | -87,4 -96,8 9.7% | -79,0 -71,7 -10.09% | -66,1 |
|
EPS USD | Released Forecast Spread | -0,93 | -1,33 -1,34 0.55% | -1,36 -1,51 9.84% | -1,22 -1,11 -9.91% | -1,01 |
| Announcement Date | 24/05/21 | 15/03/22 | 07/03/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10,9 11,2 -2.35% | 10,9 11,0 -0.81% | 11,7 12,0 -2.37% | 11,6 11,5 1.73% | 13,4 12,9 3.62% | 14,0 13,9 0.56% | 15,1 15,2 -1.19% | 16,3 15,5 5.52% | 17,0 17,3 -1.6% | 15,6 | 17,4 | 21,6 | 24,0 | 20,9 |
|
EBITDA Million USD | Released Forecast Spread | -19,8 -20,4 2.8% | -23,8 -18,8 -26.77% | -22,7 -24,0 5.45% | -22,2 -21,3 -4.2% | -13,5 -21,4 36.67% | -17,4 -16,7 -4.3% | -17,8 -17,9 0.54% | -14,3 -18,5 22.47% | -17,0 -16,1 -5.37% | -15,2 | -15,4 | -13,3 | ||
|
EBIT Million USD | Released Forecast Spread | -21,0 -21,5 2.06% | -25,0 -19,8 -26.37% | -24,1 -25,0 3.68% | -23,6 -22,5 -5.06% | -15,1 -22,7 33.58% | -19,3 -19,5 1.09% | -20,0 -19,6 -2.25% | -16,5 -20,9 20.7% | -18,9 -17,0 -11.17% | -16,3 | -14,2 | -13,5 | -12,6 | -16,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,9 -21,5 -1.86% | -25,3 -20,7 -22% | -23,4 -22,6 -3.84% | -14,2 -22,7 37.23% | -19,6 -19,4 -0.82% | -21,3 -19,6 -8.98% | -13,5 -20,8 34.99% | -24,1 -17,0 -41.62% | -17,5 | -14,6 | -14,9 | -14,4 | -16,5 | |
|
Net income Million USD | Released Forecast Spread | -21,4 -22,2 3.72% | -25,5 -21,0 -21.37% | -23,3 -22,7 -2.69% | -14,0 -22,6 38.28% | -19,7 -19,2 -2.7% | -21,4 -19,9 -7.63% | -13,8 -21,0 34.03% | -24,1 -17,1 -40.43% | -17,5 | -14,6 | -15,1 | -14,5 | -16,5 | |
|
EPS USD | Released Forecast Spread | -0,33 -0,36 7.3% | -0,40 -0,33 -21.36% | -0,39 -0,39 0.93% | -0,36 -0,36 0.92% | -0,22 -0,35 37.56% | -0,31 -0,32 1.59% | -0,33 -0,31 -8.05% | -0,21 -0,32 35.05% | -0,37 -0,26 -42.31% | -0,28 | -0,26 | -0,24 | -0,23 | -0,25 |
| Announcement Date | 15/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 05/03/24 | - | - | - | - | - |
More events
Past sector events for SOPHiA GENETICS SA
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SOPH Stock
- Calendar SOPHiA GENETICS SA
